Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5733 | 1516 | 40.5 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
214 | 20119 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEW ZEALAND MICE | Author keyword | 7 | 64% | 0% | 7 |
2 | RHEUMATOL CLIN MED | Address | 7 | 64% | 0% | 7 |
3 | MRL LPR MICE | Author keyword | 5 | 26% | 1% | 17 |
4 | MURINE LUPUS | Author keyword | 5 | 34% | 1% | 12 |
5 | SIMMONS ARTHRIT | Address | 5 | 43% | 1% | 9 |
6 | NEPHRITOGENIC ANTIBODIES | Author keyword | 3 | 100% | 0% | 3 |
7 | TOIN HUMAN SCI TECHNOL | Address | 3 | 21% | 1% | 12 |
8 | BXSB | Author keyword | 2 | 38% | 0% | 5 |
9 | PENN KIDNEY | Address | 2 | 67% | 0% | 2 |
10 | YAA GENE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEW ZEALAND MICE | 7 | 64% | 0% | 7 | Search NEW+ZEALAND+MICE | Search NEW+ZEALAND+MICE |
2 | MRL LPR MICE | 5 | 26% | 1% | 17 | Search MRL+LPR+MICE | Search MRL+LPR+MICE |
3 | MURINE LUPUS | 5 | 34% | 1% | 12 | Search MURINE+LUPUS | Search MURINE+LUPUS |
4 | NEPHRITOGENIC ANTIBODIES | 3 | 100% | 0% | 3 | Search NEPHRITOGENIC+ANTIBODIES | Search NEPHRITOGENIC+ANTIBODIES |
5 | BXSB | 2 | 38% | 0% | 5 | Search BXSB | Search BXSB |
6 | YAA GENE | 2 | 67% | 0% | 2 | Search YAA+GENE | Search YAA+GENE |
7 | CTLA4IGG | 1 | 50% | 0% | 2 | Search CTLA4IGG | Search CTLA4IGG |
8 | FAS LIGAND MUTANT | 1 | 100% | 0% | 2 | Search FAS+LIGAND+MUTANT | Search FAS+LIGAND+MUTANT |
9 | FAS MUTANT | 1 | 100% | 0% | 2 | Search FAS+MUTANT | Search FAS+MUTANT |
10 | LPR GVHD | 1 | 100% | 0% | 2 | Search LPR+GVHD | Search LPR+GVHD |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEW ZEALAND MICE | 70 | 67% | 4% | 63 |
2 | LPR LPR MICE | 50 | 34% | 8% | 118 |
3 | BXSB MICE | 42 | 58% | 3% | 49 |
4 | MURINE LUPUS | 41 | 18% | 14% | 215 |
5 | GP70 IMMUNE COMPLEXES | 32 | 85% | 1% | 17 |
6 | X NZWF1 HYBRID | 31 | 82% | 1% | 18 |
7 | NEW ZEALAND BLACK | 26 | 53% | 2% | 34 |
8 | ERYTHEMATOSUS PATHOGENESIS | 24 | 91% | 1% | 10 |
9 | SLE PATHOGENESIS | 22 | 58% | 2% | 26 |
10 | LPR MICE | 22 | 21% | 6% | 93 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE | 1991 | 1011 | 189 | 74% |
Delineating the genetic basis of systemic lupus erythematosus | 2001 | 368 | 72 | 36% |
Genetics of SLE: evidence from mouse models | 2010 | 34 | 102 | 39% |
Murine Models of Systemic Lupus Erythematosus | 2011 | 46 | 176 | 26% |
MURINE MODELS OF SYSTEMIC LUPUS-ERYTHEMATOSUS | 1985 | 1362 | 327 | 38% |
Genetic dissection of systemic lupus erythematosus | 1999 | 109 | 32 | 50% |
Genetic susceptibility to systemic lupus erythematosus | 1998 | 206 | 120 | 34% |
The central and multiple roles of B cells in lupus pathogenesis | 1999 | 178 | 184 | 27% |
THE YAA GENE MODEL OF SYSTEMIC LUPUS-ERYTHEMATOSUS | 1995 | 48 | 49 | 80% |
T cells and B cells in lupus nephritis | 2007 | 26 | 64 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RHEUMATOL CLIN MED | 7 | 64% | 0.5% | 7 |
2 | SIMMONS ARTHRIT | 5 | 43% | 0.6% | 9 |
3 | TOIN HUMAN SCI TECHNOL | 3 | 21% | 0.8% | 12 |
4 | PENN KIDNEY | 2 | 67% | 0.1% | 2 |
5 | ARTHRIT EXCELLENCE | 2 | 19% | 0.7% | 10 |
6 | IMMUNOL IMM3 | 2 | 40% | 0.3% | 4 |
7 | MOL AUTOIMMUNE DIS | 2 | 29% | 0.4% | 6 |
8 | SIMMONS ARTHRITIS | 1 | 38% | 0.2% | 3 |
9 | SPECIALIZED SYSTEM LUPUS ERYTHEMATOSUS | 1 | 30% | 0.2% | 3 |
10 | ARTHRITIS EXCELLENCE | 1 | 23% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189526 | NZB MOUSE//NZB MICE//ERYTHROCYTE BAND 3 |
2 | 0.0000137363 | IL10 GENE//INTERLEUKIN 10 PROMOTER//RHEUMATOL INTERNAL MED 3 |
3 | 0.0000134999 | ANTI DNA//ANTI DNA ANTIBODIES//ANTI DSDNA ANTIBODIES |
4 | 0.0000120231 | CHRONIC GRAFT VERSUS HOST REACTION//HAROLD TANENBAUM SUITE 435 600 UNIV AVE//TH 2 CYTOKINE |
5 | 0.0000103861 | ANTIGEN FREE MICE//X RAYS EXPOSURE//PGP 1 |
6 | 0.0000099560 | B 1 CELLS//B1 CELL//CD5 B LYMPHOCYTES |
7 | 0.0000091538 | MURINE MODELS OF SLE//LI AND NZB W MICE//LI AND RENAL DISEASE |
8 | 0.0000087985 | EXTRATHYMIC T CELLS//EXTRATHYMIC T CELL//INTERMEDIATE TCR CELL |
9 | 0.0000087598 | REFLEXOL MANUAL THER Y//5 HYDROXYTRYPTAMINE1A//WORLDWIDE RD |
10 | 0.0000086196 | AUTOLOGOUS MIXED LYMPHOCYTE REACTION//AUTOLOGOUS MIXED LYMPHOCYTE REACTION AMLR//MALIGNANT T CELLS |